GSP Crop Science Ltd

GSP Crop Science Ltd

₹ 353 -0.93%
25 Mar - close price
About

Company mejorly focusing on fungiside and insecticide and related pesticide

Key Points

Business Profile[1]
The Company is a research-driven agrochemical company with 40+ years of experience since 1985, focused on the development, manufacturing, and distribution of crop protection products across two verticals — Formulations (finished products) and Technicals (active ingredients).

  • Market Cap 1,642 Cr.
  • Current Price 353
  • High / Low 375 / 327
  • Stock P/E 20.2
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 20.7 %
  • ROE 19.8 %
  • Face Value 10.0

Pros

Cons

  • The company has delivered a poor sales growth of 7.34% over past five years.
  • Company has a low return on equity of 13.7% over last 3 years.
  • Dividend payout has been low at 3.46% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2025
844
709
Operating Profit 136
OPM % 16%
3
Interest 17
Depreciation 14
Profit before tax 108
Tax % 25%
81
EPS in Rs 21.22
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
903 1,077 1,406 1,203 1,152 1,287
832 949 1,273 1,125 1,028 1,137
Operating Profit 72 129 132 79 124 150
OPM % 8% 12% 9% 7% 11% 12%
4 11 13 6 12 14
Interest 25 18 24 37 34 31
Depreciation 18 18 20 21 20 23
Profit before tax 34 103 101 27 82 110
Tax % 36% 34% 25% 21% 26% 26%
21 68 76 22 61 82
EPS in Rs 72.32 229.88 256.41 77.84 235.61 21.05
Dividend Payout % 10% 4% 4% 3% 4% 4%
Compounded Sales Growth
10 Years: %
5 Years: 7%
3 Years: -3%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: 31%
3 Years: 2%
TTM: 33%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 15%
3 Years: 14%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 29 29 29 27 26 39 39
Reserves 302 366 439 336 344 411 491
169 139 321 324 235 296 323
242 383 426 444 374 483 639
Total Liabilities 742 918 1,216 1,132 980 1,228 1,492
159 161 166 169 177 214 240
CWIP 7 9 11 16 51 50 40
Investments 2 0 2 3 8 12 19
573 747 1,037 945 745 952 1,192
Total Assets 742 918 1,216 1,132 980 1,228 1,492

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
80 114 -43 104 207 38
-24 -19 -42 -47 -19 -80
-59 -50 157 -159 -178 30
Net Cash Flow -3 45 71 -102 10 -12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 113 99 96 126 103 110
Inventory Days 119 153 148 155 111 173
Days Payable 113 162 125 156 114 161
Cash Conversion Cycle 120 90 119 125 99 122
Working Capital Days 54 51 61 56 39 50
ROCE % 23% 19% 8% 17% 21%

Shareholding Pattern

Numbers in percentages

8 Recently
Mar 2026
71.72%
11.85%
5.90%
10.53%
No. of Shareholders 34,072

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents